Sigma Healthcare May Benefit From UK's Pharmacy Store Regulation, Says Jefferies

MT Newswires Live12-16 09:16

Sigma Healthcare's (ASX:SIG) Chemist Warehouse Group can potentially benefit from the United Kingdom's pharmacy location rules, according to a Monday Jefferies note.

The UK's pharmacy location rules make it difficult to move licences to new locations, leading to chronic low dispensing margins, which have weakened the sector and resulted in several high-profile market exits, the note said.

This may create an opportunity for a front-of-house focused operator such as Chemist Warehouse Group, provided it owns the required licences.

The investment firm believes that SIG shareholders have access to "excellent" retail franchise exposure from Chemist Warehouse. However, Jefferies said that SIG stock is "not cheap."

Jefferies kept a hold rating on Sigma with a price target of AU$2.90.

The company's shares rose 2% in recent Tuesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment